Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study

Makoto Tahara, Richard Greil, Danny Rischin, Kevin J. Harrington, Barbara Burtness, Gilberto de Castro, Amanda Psyrri, Irene Braña, Prakash Neupane, Åse Bratland, Thorsten Fuereder, Brett Hughes, Ricard Mesı́a, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Jianxin Lin, Burak Gümüşçü, Nati Lerman, Denis Soulières